Millie
your market intelligence analyst
Search Results
324 results
Your search is now limited to «AstraZeneca» expert search.
NASDAQ 10/22/2019 11:02
Today's Research Daily features new research reports on 16 major stocks, including Walmart, AstraZeneca and Broadcom.
More from NASDAQ:
FDA approves AstraZeneca’s Farxiga to treat heart failure in diabetic.
More from Pharmaceutical Business Review:
Benzinga 10/21/2019 12:42
Farxiga now offers the opportunity for physicians to act sooner and reduce the risk of hospitalization for heart failure," said Ruud Dobber, executive vice president of AstraZeneca's biopharma unit, said in a statement.
More from Benzinga:
News-Medical.net 10/21/2019 11:09
The collaboration with AstraZeneca is an early step in this direction, and we are fortunate to be involved in such a promising growth", says Alexey Amunts.
More from News-Medical.net:
FiercePharmaManufacturing 10/21/2019 10:54
The FDA’s expedited review will cover Farxiga’s pursuit of indications in both HFrEF and heart failure patients with a preserved ejection fraction, AstraZeneca said at the time.
More from FiercePharmaManufacturing:
ENDPOINTS 10/21/2019 08:55
In September, AstraZeneca unveiled data from the DAPA-HF trial, which showed the drug cut the risk of CV death or the worsening of heart failure in patients with heart disease.
More from ENDPOINTS:
ETHealthWorld (India) 10/21/2019 03:07
The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the British drugmaker said and follows a similar approval by the European authorities in August.
More from ETHealthWorld (India):
Reuters.com 10/21/2019 02:35
AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks.
More from Reuters.com:
Channel NewsAsia (Singapore) 10/21/2019 02:35
US FDA approves AstraZeneca's diabetes drug for treating heart failure risk.
More from Channel NewsAsia (Singapore):
Updated Date: Fri, 18 Oct 2019 00:00:00 EDT.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PharmaTimes 10/17/2019 06:40
AstraZeneca and Daiichi Sankyo's trastuzumab deruxtecan has taken a step closer to US approval having been accepted for priority review by the US Food and Drug Administration (FDA) for breast cancer.
More from PharmaTimes:
Reuters.com 10/17/2019 02:29
AstraZeneca gets FDA priority review for experimental breast cancer drug.
More from Reuters.com:
Business Wire 10/16/2019 08:00
PetaGene announces collaboration with AstraZeneca to deploy its genomic data compression software in core genomics initiative.
More from Business Wire:
(MENAFN - Market Research Explore) The Global Eosinophilic Esophagitis Drug Market research report focuses on exploring the developments and growth strategies of the global Eosinop...
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications